Users are also advised to cycle GHK-Cu rather than staying on it year-round
doi: 10.3389/fimmu.2024.1466023 Received 17 July 2024 Accepted 09 September 2024 Published 25 September 2024 Volume 15 - 2024 Edited by Reza Akbarzadeh, University of Lbeck, Germany Reviewed by Maximiliano Jimenez Dalmaroni, National University of La Plata, Argentina Bernhard Ryffel, Centre National de la Recherche Scientifique (CNRS), France Jrmie Decalf, Genentech Inc., United States Updates Copyright 2024 Zhu and Zhou
What has changed
Alternative approaches to consider If Brello does not feel like the right fit, or if you want to explore all options before committing, consider: Oral tirzepatide options that eliminate injection anxiety entirely Tirzepatide sublingual drops as a needle-free alternative Orally disintegrating tablets for convenient dosing Phentermine comparison if you are weighing older weight loss medications against GLP-1 options Retatrutide , a next-generation triple agonist still in clinical trials but showing promising results For researchers interested in the broader peptide landscape, understanding how tirzepatide compares to emerging compounds like survodutide , orforglipron , and CagriSema provides valuable perspective on where GLP-1 therapy is heading